US 12291502
Topoisomerase II-alpha inhibitors and methods of treating cancer using the same
granted A61KA61K31/4709A61K31/5377
Quick answer
US patent 12291502 (Topoisomerase II-alpha inhibitors and methods of treating cancer using the same) held by The Regents of the University of Colorado, a Body Corporate expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/4709, A61K31/5377, A61K45/06, A61P